NVIDIA (NVDA) 10-Q 19 Nov 21 2022 Q3 Quarterly report Financial data

Cover

Cover - shares shares in Millions	9 Months Ended
	Oct. 31, 2021	Nov. 12, 2021
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2021
Document Transition Report	false
Entity File Number	0-23985
Entity Registrant Name	NVIDIA CORP
Entity Central Index Key	0001045810
Current Fiscal Year End Date	--01-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3177549
Entity Address, Address Line One	2788 San Tomas Expressway
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95051
City Area Code	408
Local Phone Number	486-2000
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	NVDA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,500

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Income Statement [Abstract]
Revenue	$ 7,103	$ 4,726	$ 19,271	$ 11,672
Cost of revenue	2,472	1,766	6,795	4,432
Gross profit	4,631	2,960	12,476	7,240
Operating expenses
Research and development	1,403	1,047	3,802	2,778
Sales, general and administrative	557	515	1,603	1,437
Total operating expenses	1,960	1,562	5,405	4,215
Income from operations	2,671	1,398	7,071	3,025
Interest income	7	7	20	50
Interest expense	(62)	(53)	(175)	(131)
Other, net	22	(4)	160	(5)
Other income (expense), net	(33)	(50)	5	(86)
Income before income tax	2,638	1,348	7,076	2,939
Income tax expense	174	12	327	64
Net income	$ 2,464	$ 1,336	$ 6,749	$ 2,875
Net income per share:
Basic (in dollars per share)	$ 0.99	$ 0.54	$ 2.71	$ 1.17
Diluted (in dollars per share)	$ 0.97	$ 0.53	$ 2.67	$ 1.15
Weighted average shares used in per share computation:
Basic (in shares)	2,499	2,472	2,493	2,464
Diluted (in shares)	2,538	2,520	2,532	2,504

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Statement of Comprehensive Income [Abstract]
Net income	$ 2,464	$ 1,336	$ 6,749	$ 2,875
Available-for-sale securities:
Net change in unrealized gain (loss)	(4)	(1)	(5)	3
Reclassification adjustments for net realized gain (loss) included in net income	0	0	0	(2)
Net change in unrealized gain (loss)	(4)	(1)	(5)	1
Cash flow hedges:
Net unrealized gain (loss)	22	5	(5)	10
Reclassification adjustments for net realized gain (loss) included in net income	(17)	4	0	0
Net change in unrealized gain (loss)	5	9	(5)	10
Other comprehensive income (loss), net of tax	1	8	(10)	11
Total comprehensive income	$ 2,465	$ 1,344	$ 6,739	$ 2,886

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,288	$ 847
Marketable securities	18,010	10,714
Accounts receivable, net	3,954	2,429
Inventories	2,233	1,826
Prepaid expenses and other current assets	321	239
Total current assets	25,806	16,055
Property and equipment, net	2,509	2,149
Operating lease assets	830	707
Goodwill	4,302	4,193
Intangible assets, net	2,454	2,737
Deferred income tax assets	970	806
Other assets	3,761	2,144
Total assets	40,632	28,791
Current liabilities:
Accounts payable	1,664	1,201
Accrued and other current liabilities	1,948	1,725
Short-term debt	0	999
Total current liabilities	3,612	3,925
Long-term debt	10,944	5,964
Long-term operating lease liabilities	743	634
Other long-term liabilities	1,535	1,375
Total liabilities	16,834	11,898
Commitments and contingencies - see Note 13
Shareholders’ equity:
Preferred stock	0	0
Common stock	3	3
Additional paid-in capital	10,465	8,719
Treasury stock, at cost	(12,038)	(10,756)
Accumulated other comprehensive income	9	19
Retained earnings	25,359	18,908
Total shareholders' equity	23,798	16,893
Total liabilities and shareholders' equity	$ 40,632	$ 28,791

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock Outstanding	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income	Retained Earnings
Beginning balance, common stock outstanding (in shares) at Jan. 26, 2020		2,450
Beginning balances, shareholders' equity at Jan. 26, 2020	$ 12,204	$ 3	$ 7,043	$ (9,814)	$ 1	$ 14,971
Increase (Decrease) in Shareholders' Equity
Net income	2,875					2,875
Other comprehensive income (loss)	11				11
Issuance of common stock from stock plans (in shares)		34
Issuance of common stock from stock plans	190		190
Tax withholding related to vesting of restricted stock units (in shares)		(9)
Tax withholding related to vesting of restricted stock units	(716)			(716)
Cash dividends declared and paid	(296)					(296)
Fair value of partially vested equity awards assumed in connection with acquisitions	86		86
Stock-based compensation	980		980
Ending balance, common stock outstanding (in shares) at Oct. 25, 2020		2,475
Ending balances, shareholders' equity at Oct. 25, 2020	15,334	$ 3	8,299	(10,530)	12	17,550
Beginning balance, common stock outstanding (in shares) at Jul. 26, 2020		2,467
Beginning balances, shareholders' equity at Jul. 26, 2020	13,914	$ 3	7,826	(10,232)	4	16,313
Increase (Decrease) in Shareholders' Equity
Net income	1,336					1,336
Other comprehensive income (loss)	8				8
Issuance of common stock from stock plans (in shares)		10
Issuance of common stock from stock plans	96		96
Tax withholding related to vesting of restricted stock units (in shares)		(2)
Tax withholding related to vesting of restricted stock units	(298)			(298)
Cash dividends declared and paid	(99)					(99)
Stock-based compensation	377		377
Ending balance, common stock outstanding (in shares) at Oct. 25, 2020		2,475
Ending balances, shareholders' equity at Oct. 25, 2020	15,334	$ 3	8,299	(10,530)	12	17,550
Beginning balance, common stock outstanding (in shares) at Jan. 31, 2021		2,479
Beginning balances, shareholders' equity at Jan. 31, 2021	16,893	$ 3	8,719	(10,756)	19	18,908
Increase (Decrease) in Shareholders' Equity
Net income	6,749					6,749
Other comprehensive income (loss)	(10)				(10)
Issuance of common stock from stock plans (in shares)		30
Issuance of common stock from stock plans	277		277
Tax withholding related to vesting of restricted stock units (in shares)		(7)
Tax withholding related to vesting of restricted stock units	(1,282)			(1,282)
Cash dividends declared and paid	(298)					(298)
Fair value of partially vested equity awards assumed in connection with acquisitions	18		18
Stock-based compensation	1,451		1,451
Ending balance, common stock outstanding (in shares) at Oct. 31, 2021		2,502
Ending balances, shareholders' equity at Oct. 31, 2021	23,798	$ 3	10,465	(12,038)	9	25,359
Beginning balance, common stock outstanding (in shares) at Aug. 01, 2021		2,496
Beginning balances, shareholders' equity at Aug. 01, 2021	21,147	$ 3	9,745	(11,604)	8	22,995
Increase (Decrease) in Shareholders' Equity
Net income	2,464					2,464
Other comprehensive income (loss)	1				1
Issuance of common stock from stock plans (in shares)		8
Issuance of common stock from stock plans	150		150
Tax withholding related to vesting of restricted stock units (in shares)		(2)
Tax withholding related to vesting of restricted stock units	(434)			(434)
Cash dividends declared and paid	(100)					(100)
Fair value of partially vested equity awards assumed in connection with acquisitions	18		18
Stock-based compensation	552		552
Ending balance, common stock outstanding (in shares) at Oct. 31, 2021		2,502
Ending balances, shareholders' equity at Oct. 31, 2021	$ 23,798	$ 3	$ 10,465	$ (12,038)	$ 9	$ 25,359

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Statement of Stockholders' Equity [Abstract]
Common stock, dividends per share, declared and paid (in dollars per share)	$ 0.04	$ 0.04	$ 0.12	$ 0.12

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020
Cash flows from operating activities:
Net income	$ 6,749	$ 2,875
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	1,453	981
Depreciation and amortization	865	810
Deferred income taxes	(182)	(117)
(Gains) losses on investments in non-affiliates, net	(152)	9
Other	25	(11)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(1,523)	(667)
Inventories	(400)	(190)
Prepaid expenses and other assets	(1,557)	(409)
Accounts payable	474	289
Accrued and other current liabilities	70	111
Other long-term liabilities	253	74
Net cash provided by operating activities	6,075	3,755
Cash flows from investing activities:
Proceeds from maturities of marketable securities	7,780	5,165
Proceeds from sales of marketable securities	916	502
Purchases of marketable securities	(16,020)	(12,840)
Purchases related to property and equipment and intangible assets	(703)	(845)
Acquisitions, net of cash acquired	(203)	(8,524)
Investments and other, net	(14)	(4)
Net cash used in investing activities	(8,244)	(16,546)
Cash flows from financing activities:
Issuance of debt, net of issuance costs	4,977	4,971
Proceeds related to employee stock plans	277	190
Payments related to tax on restricted stock units	(1,282)	(716)
Repayment of debt	(1,000)	0
Dividends paid	(298)	(296)
Principal payments on property and equipment	(62)	0
Other	(2)	(3)
Net cash provided by financing activities	2,610	4,146
Change in cash and cash equivalents	441	(8,645)
Cash and cash equivalents at beginning of period	847	10,896
Cash and cash equivalents at end of period	$ 1,288	$ 2,251

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. The January 31, 2021 consolidated balance sheet was derived from our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, as filed with the SEC, but does not include all disclosures required by U.S. GAAP. In the opinion of management, all adjustments, consisting only of normal recurring adjustments considered necessary for a fair statement of results of operations and financial position, have been included. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021. On May 21, 2021, our Board of Directors declared a four-for-one split of our common stock in the form of a stock dividend, or the Stock Split, which was conditioned upon obtaining stockholder approval to increase the number of our authorized shares of common stock from 2 billion to 4 billion. On June 3, 2021, at the 2021 Annual Meeting of Stockholders, our stockholders approved the amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock to 4 billion. As a result, each stockholder of record at the close of business on June 21, 2021 received a dividend of three additional shares of common stock for every share held on the record date, distributed after the close of trading on July 19, 2021. All share, equity award, and per share amounts and related shareholders' equity balances presented herein have been retroactively adjusted to reflect the Stock Split. Significant Accounting Policies There have been no material changes to our significant accounting policies disclosed in Note 1 - Organization and Summary of Significant Accounting Policies, of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021. Fiscal Year We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal year 2022 is a 52-week year and fiscal year 2021 was a 53-week year. The third quarters of fiscal years 2022 and 2021 were both 13-week quarters. Reclassifications Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation. Principles of Consolidation Our condensed consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. The inputs into our judgments and estimates consider the economic implications of COVID-19. These estimates are based on historical facts and various other assumptions that we believe are reasonable. Adoption of New and Recently Issued Accounting Pronouncement Recently Adopted Accounting Pronouncement In October 2021, the Financial Accounting Standards Board issued a new accounting standard to require that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers . We early adopted this accounting standard in the third quarter of fiscal year 2022 and the impact was immaterial.

Business Combination

Business Combination	9 Months Ended
	Oct. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Business Combination	Business Combination Pending Acquisition of Arm Limited On September 13, 2020, we entered into a Share Purchase Agreement, or the Purchase Agreement, with Arm Limited, or Arm, and SoftBank Group Capital Limited and SVF Holdco (UK) Limited, or together, SoftBank, to acquire, from SoftBank, all allotted and issued ordinary shares of Arm in a transaction valued at $40 billion. We paid $2 billion in cash at signing, or the Signing Consideration, and will pay upon closing of the acquisition $10 billion in cash and issue to SoftBank 177.5 million shares of our common stock, which had an aggregate value of $21.5 billion as of the date of the Purchase Agreement, and was valued at $56.2 billion as of November 18, 2021. The transaction includes a potential earn out, which is contingent on the achievement of certain financial performance targets by Arm during the fiscal year ending March 31, 2022. If the financial targets are achieved, SoftBank can elect to receive either up to an additional $5 billion in cash or up to an additional 41.3 million shares of our common stock, which was valued at $13.1 billion as of November 18, 2021. We will issue up to $1.5 billion in restricted stock units to Arm employees after closing. The Signing Consideration was allocated between advanced consideration for the acquisition of $1.36 billion and the prepayment of intellectual property licenses from Arm of $0.17 billion and royalties of $0.47 billion, both with a 20-year term. The Signing Consideration was allocated on a fair value basis and any refund of the Signing Consideration will use stated values in the Purchase Agreement. The Purchase Agreement can be terminated by either party if the transaction has not closed by September 2022, subject to certain qualifications. If the transaction does not close due to failure to receive regulatory approval, and all other covenants have been met, we will not be refunded $1.25 billion of the advanced consideration for the acquisition we paid at signing. The closing of the acquisition is subject to customary closing conditions, including receipt of specified governmental and regulatory consents and approvals and the expiration of any related mandatory waiting period, and Arm's implementation of the reorganization and distribution of Arm’s IoT Services Group and certain other assets and liabilities. We are seeking regulatory approval in the United States, the United Kingdom, the European Union, China and other jurisdictions. Regulators at the United States Federal Trade Commission, or the FTC, have expressed concerns regarding the transaction, and we are engaged in discussions with the FTC regarding remedies to address those concerns. The transaction has been under the review of China’s antitrust authority, pending the formal case initiation. Regulators in the United Kingdom and the European Union declined to approve the transaction in Phase 1 of their review processes, expressed numerous concerns, began a more in-depth Phase 2 review on the transaction’s impact on competition, and, in the United Kingdom, a Phase 2 review of the impact on the United Kingdom’s national security interests. Although regulators and some Arm licensees have expressed concerns or objected to the transaction, we continue to believe in the merits and benefits of the acquisition to Arm, its licensees, and the industry. Acquisition of Mellanox Technologies, Ltd. On April 27, 2020, we completed the acquisition of all outstanding shares of Mellanox for a total purchase consideration of $7.13 billion. Mellanox is a supplier of high-performance interconnect products for computing, storage and communications applications. We acquired Mellanox to optimize data center workloads to scale across the entire computing, networking, and storage stack. Supplemental Unaudited Pro Forma Information The following unaudited pro forma financial information summarizes the combined results of operations for NVIDIA and Mellanox as if the companies were combined as of the beginning of fiscal year 2020: Pro Forma Three Months Ended Nine Months Ended October 25, 2020 October 25, 2020 (In millions) Revenue $ 4,726 $ 12,101 Net income $ 1,388 $ 3,267 The unaudited pro forma information includes adjustments related to amortization of acquired intangible assets, adjustments to stock-based compensation expense, fair value of acquired inventory, and transaction costs. The unaudited pro forma information presented above is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition occurred at the beginning of fiscal year 2020 or of the results of our future operations of the combined businesses.

Leases

Leases	9 Months Ended
	Oct. 31, 2021
Leases [Abstract]
Leases	Leases Our lease obligations primarily consist of operating leases for our headquarters complex, domestic and international office facilities, and data center space, with lease periods expiring between fiscal years 2022 and 2035. Future minimum lease payments under our non-cancelable operating leases as of October 31, 2021, are as follows: Operating Lease Obligations (In millions) Fiscal Year: 2022 (excluding first nine months of fiscal year 2022) $ 43 2023 169 2024 152 2025 128 2026 118 2027 and thereafter 385 Total 995 Less imputed interest 112 Present value of net future minimum lease payments 883 Less short-term operating lease liabilities 140 Long-term operating lease liabilities $ 743 In addition to our existing operating lease obligations, we have operating leases that are expected to commence between the fourth quarter of fiscal year 2022 and fiscal year 2023 with lease terms of 7 years for $132 million. Operating lease expenses were $44 million and $37 million for the third quarter of fiscal years 2022 and 2021, respectively, and $125 million and $104 million for the first nine months of fiscal years 2022 and 2021, respectively. Short-term and variable lease expenses for the third quarter and first nine months of fiscal years 2022 and 2021 were not significant. Other information related to leases was as follows: Nine Months Ended October 31, 2021 October 25, 2020 (In millions) Supplemental cash flows information Operating cash flows used for operating leases $ 114 $ 103 Operating lease assets obtained in exchange for lease obligations $ 230 $ 147 As of October 31, 2021, our operating leases had a weighted average remaining lease term of 7.3 years and a weighted average discount rate of 2.54%. As of January 31, 2021, our operating leases had a weighted average remaining lease term of 7.6 years and a weighted average discount rate of 2.87%.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Our stock-based compensation expense is associated with restricted stock units, or RSUs, performance stock units that are based on our corporate financial performance targets, or PSUs, performance stock units that are based on market conditions, or market-based PSUs, and our employee stock purchase plan, or ESPP. Our Condensed Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, (In millions) Cost of revenue $ 44 $ 28 $ 102 $ 62 Research and development 363 232 935 594 Sales, general and administrative 152 123 416 325 Total $ 559 $ 383 $ 1,453 $ 981 Equity Award Activity The following is a summary of equity award transactions under our equity incentive plans: RSUs, PSUs, and Market-based PSUs Outstanding Number of Shares Weighted Average Grant-Date Fair Value Per Share (In millions, except per share data) Balances, January 31, 2021 59 $ 66.17 Granted 17 $ 184.63 Vested restricted stock (23) $ 62.39 Canceled and forfeited (1) $ 80.50 Balances, October 31, 2021 52 $ 107.42 As of October 31, 2021, there was $5.16 billion of aggregate unearned stock-based compensation expense, net of forfeitures. This amount is expected to be recognized over a weighted average period of 2.6 years for RSUs, PSUs, and market-based PSUs, and 1 year for ESPP.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, 2021 2020 2021 2020 (In millions, except per share data) Numerator: Net income $ 2,464 $ 1,336 $ 6,749 $ 2,875 Denominator: Basic weighted average shares 2,499 2,472 2,493 2,464 Dilutive impact of outstanding equity awards 39 48 39 40 Diluted weighted average shares 2,538 2,520 2,532 2,504 Net income per share: Basic (1) $ 0.99 $ 0.54 $ 2.71 $ 1.17 Diluted (2) $ 0.97 $ 0.53 $ 2.67 $ 1.15 Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive 2 — 21 32 (1) Calculated as net income divided by basic weighted average shares. (2) Calculated as net income divided by diluted weighted average shares.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We recognized an income tax expense of $174 million and $327 million for the third quarter and first nine months of fiscal year 2022, respectively, and an income tax expense of $12 million and $64 million for the third quarter and first nine months of fiscal year 2021, respectively. The income tax expense as a percentage of income before income tax was 6.6% and 4.6% for the third quarter and first nine months of fiscal year 2022, respectively, and 0.9% and 2.2% for the third quarter and first nine months of fiscal year 2021, respectively. On June 28, 2021, we simplified our corporate structure by repatriating the economic rights of certain non-U.S. intellectual property to the United States via domestication of a foreign subsidiary, or the Domestication. The Domestication more closely aligns our corporate structure to our operating structure in accordance with the Organization for Economic Cooperation and Development’s Base Erosion and Profit Shifting conclusions and changes to U.S. and European tax laws. The impact of the Domestication, which is regarded as a change in tax status, resulted in a discrete benefit primarily from re-valuing certain deferred tax assets, net of deferred tax liabilities, of $252 million in the second quarter of fiscal year 2022. The increase in our effective tax rate for the third quarter and first nine months of fiscal year 2022 as compared to the same periods of fiscal year 2021 was primarily due to an increase in the amount of earnings subject to U.S. tax, and a decreased impact of tax benefits from stock-based compensation and the U.S. federal research tax credit, partially offset, for the first nine months, by the discrete benefit of the Domestication. Our effective tax rate for the first nine months of fiscal year 2021 was lower than the U.S. federal statutory rate of 21% due to income earned in jurisdictions that are subject to taxes lower than the U.S. federal statutory tax rate, the benefit of the U.S. federal research tax credit, and tax benefits related to stock-based compensation. Our effective tax rate for the first nine months of fiscal year 2022 was lower than the U.S. federal statutory rate of 21% due to tax benefits from the foreign-derived intangible income deduction, income earned in jurisdictions that are subject to taxes lower than the U.S. federal statutory tax rate, the discrete benefit of the Domestication, and tax benefits related to stock-based compensation and the U.S. federal research tax credit. As of October 31, 2021, we intend to indefinitely reinvest approximately $1.7 billion and $231 million of cumulative undistributed earnings held by certain subsidiaries in Israel and the United Kingdom, respectively. We have not provided the amount of unrecognized deferred tax liabilities for temporary differences related to these investments as the determination of such amount is not practicable. For the first nine months of fiscal year 2022, there have been no material changes to our tax years that remain subject to examination by major tax jurisdictions. We are currently under examination by the Internal Revenue Service for our fiscal years 2018 and 2019. Additionally, there have been no material changes to our unrecognized tax benefits and any related interest or penalties since the fiscal year ended January 31, 2021.

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	9 Months Ended
	Oct. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	Cash Equivalents and Marketable Securities Our cash equivalents and marketable securities related to debt securities are classified as “available-for-sale” debt securities. The following is a summary of cash equivalents and marketable securities as of October 31, 2021 and January 31, 2021: October 31, 2021 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 9,179 $ 2 $ (1) $ 9,180 $ 135 $ 9,045 Debt securities issued by the United States Treasury 4,887 — (2) 4,885 195 4,690 Debt securities issued by United States government agencies 2,861 — — 2,861 307 2,554 Certificates of deposit 1,512 — — 1,512 32 1,480 Money market funds 360 — — 360 360 — Foreign government bonds 241 — — 241 — 241 Total $ 19,040 $ 2 $ (3) $ 19,039 $ 1,029 $ 18,010 January 31, 2021 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 4,442 $ 2 $ — $ 4,444 $ 234 $ 4,210 Debt securities issued by United States government agencies 2,975 1 — 2,976 28 2,948 Debt securities issued by the United States Treasury 2,846 — — 2,846 25 2,821 Certificates of deposit 705 — — 705 37 668 Money market funds 313 — — 313 313 — Foreign government bonds 67 — — 67 — 67 Total $ 11,348 $ 3 $ — $ 11,351 $ 637 $ 10,714 Net realized gains and unrealized gains and losses were not significant for all periods presented. The amortized cost and estimated fair value of cash equivalents and marketable securities as of October 31, 2021 and January 31, 2021 are shown below by contractual maturity. October 31, 2021 January 31, 2021 Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value (In millions) Less than one year $ 16,243 $ 16,244 $ 10,782 $ 10,783 Due in 1 - 5 years 2,797 2,795 566 568 Total $ 19,040 $ 19,039 $ 11,348 $ 11,351

Fair Value of Financial Assets

Fair Value of Financial Assets and Liabilities	9 Months Ended
	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value of Financial Assets and Liabilities	Fair Value of Financial Assets and LiabilitiesThe fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active markets. We review fair value hierarchy classification on a quarterly basis. Fair Value at Pricing Category October 31, 2021 January 31, 2021 (In millions) Assets Cash equivalents and marketable securities: Money market funds Level 1 $ 360 $ 313 Corporate debt securities Level 2 $ 9,180 $ 4,444 Debt securities issued by the United States Treasury Level 2 $ 4,885 $ 2,846 Debt securities issued by United States government agencies Level 2 $ 2,861 $ 2,976 Certificates of deposit Level 2 $ 1,512 $ 705 Foreign government bonds Level 2 $ 241 $ 67 Other assets (Investment in non-affiliated entities): Publicly-held equity security (1) Level 1 $ 136 $ — Privately-held equity securities Level 3 $ 172 $ 144 Liabilities (2) 2.20% Notes Due 2021 Level 2 $ — $ 1,011 0.309% Notes Due 2023 Level 2 $ 1,247 $ — 0.584% Notes Due 2024 Level 2 $ 1,244 $ — 3.20% Notes Due 2026 Level 2 $ 1,086 $ 1,124 1.55% Notes Due 2028 Level 2 $ 1,233 $ — 2.85% Notes Due 2030 Level 2 $ 1,597 $ 1,654 2.00% Notes Due 2031 Level 2 $ 1,239 $ — 3.50% Notes Due 2040 Level 2 $ 1,118 $ 1,152 3.50% Notes Due 2050 Level 2 $ 2,285 $ 2,308 3.70% Notes Due 2060 Level 2 $ 594 $ 602 (1) Unrealized gains of $8 million and $126 million from an investment in a publicly-traded equity security were recorded in other income (expense), net, in the third quarter and first nine months of fiscal year 2022, respectively. (2) These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.

Amortizable Intangible Assets a

Amortizable Intangible Assets and Goodwill	9 Months Ended
	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortizable Intangible Assets and Goodwill	Amortizable Intangible Assets and Goodwill The components of our amortizable intangible assets are as follows: October 31, 2021 January 31, 2021 Gross Accumulated Net Carrying Gross Accumulated Net Carrying (In millions) Acquisition-related intangible assets (1) $ 3,396 $ (1,166) $ 2,230 $ 3,280 $ (774) $ 2,506 Patents and licensed technology 709 (485) 224 706 (475) 231 Total intangible assets $ 4,105 $ (1,651) $ 2,454 $ 3,986 $ (1,249) $ 2,737 (1) As of October 31, 2021, acquisition-related intangible assets include the fair value of a Mellanox in-process research and development project of $630 million, which has not yet commenced amortization. Amortization expense associated with intangible assets was $143 million and $418 million for the third quarter and first nine months of fiscal year 2022, respectively, and $174 million and $465 million for the third quarter and first nine months of fiscal year 2021, respectively. Future amortization expense related to the net carrying amount of intangible assets, excluding in-process research and development, as of October 31, 2021 is estimated to be $145 million for the remainder of fiscal year 2022, $576 million in fiscal year 2023, $453 million in fiscal year 2024, $400 million in fiscal year 2025, $117 million in fiscal year 2026, and $133 million in fiscal year 2027 and thereafter.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Certain balance sheet components are as follows: October 31, January 31, 2021 2021 Inventories: (In millions) Raw materials $ 755 $ 632 Work in-process 538 457 Finished goods 940 737 Total inventories $ 2,233 $ 1,826 October 31, January 31, 2021 2021 Other assets: (In millions) Prepaid supply agreements $ 1,606 $ — Advanced consideration for acquisition 1,357 1,357 Prepaid royalties 416 440 Investment in non-affiliated entities 308 144 Deposits 22 136 Other 52 67 Total other assets $ 3,761 $ 2,144 October 31, January 31, 2021 2021 Accrued and Other Current Liabilities: (In millions) Customer program accruals $ 857 $ 630 Deferred revenue (1) 298 288 Accrued payroll and related expenses 295 297 Operating leases 140 121 Licenses and royalties 108 128 Product warranty and return provisions 45 39 Coupon interest on debt obligations 37 74 Taxes payable 36 61 Professional service fees 30 26 Other 102 61 Total accrued and other current liabilities $ 1,948 $ 1,725 (1) Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements and post-contract customer support, or PCS. October 31, January 31, 2021 2021 Other Long-Term Liabilities: (In millions) Income tax payable (1) $ 1,051 $ 836 Deferred income tax 225 241 Deferred revenue (2) 191 163 Employee benefits 38 33 Licenses payable 21 56 Other 9 46 Total other long-term liabilities $ 1,535 $ 1,375 (1) As of October 31, 2021, income tax payable represents the long-term portion of the one-time transition tax payable of $251 million, unrecognized tax benefits of $578 million, related interest and penalties of $60 million, and other foreign long-term tax payable of $162 million. (2) Deferred revenue primarily includes deferrals related to PCS. Deferred Revenue The following table shows the changes in deferred revenue during the first nine months of fiscal years 2022 and 2021: October 31, October 25, 2021 2020 (In millions) Balance at beginning of period $ 451 $ 201 Deferred revenue added during the period 621 361 Addition due to business combinations — 75 Revenue recognized during the period (583) (255) Balance at end of period $ 489 $ 382 Revenue related to remaining performance obligations represents the contracted license, development arrangements and PCS that has not been recognized. This includes deferred revenue currently recorded and amounts that will be invoiced in future periods. As of October 31, 2021, $620 million of revenue related to performance obligations had not been recognized, of which we expect to recognize approximately 49% over the next 12 months and the remainder thereafter. This excludes revenue related to performance obligations for contracts with a length of one year or less.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Oct. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments We enter into foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. These contracts are designated as cash flow hedges for hedge accounting treatment. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings or ineffectiveness should occur. The fair value of the contracts was not significant as of October 31, 2021 and January 31, 2021. We also enter into foreign currency forward contracts to mitigate the impact of foreign currency movements on monetary assets and liabilities that are denominated in currencies other than the U.S. dollar. These forward contracts were not designated for hedge accounting treatment. Therefore, the change in fair value of these contracts is recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which is also recorded in other income or expense. The table below presents the notional value of our foreign currency forward contracts outstanding as of October 31, 2021 and January 31, 2021: October 31, January 31, (In millions) Designated as cash flow hedges $ 949 $ 840 Not designated for hedge accounting $ 430 $ 441 As of October 31, 2021, all designated foreign currency forward contracts mature within 18 months. The expected realized gains and losses deferred into accumulated other comprehensive income or loss related to foreign currency forward contracts within the next 12 months was not significant. During the first nine months of fiscal years 2022 and 2021, the impact of derivative financial instruments designated for hedge accounting treatment on other comprehensive income or loss was not significant.

Debt

Debt	9 Months Ended
	Oct. 31, 2021
Debt Disclosure [Abstract]
Debt	Debt Long-Term Debt In June 2021, we issued $1.25 billion of the 0.309% Notes Due 2023, $1.25 billion of the 0.584% Notes Due 2024, $1.25 billion of the 1.55% Notes Due 2028, and $1.25 billion of the 2.00% Notes Due 2031, or collectively, the June 2021 Notes. Interest on the 0.584% Notes Due 2024 is payable on June 14 and December 14 of each year, beginning on December 14, 2021. Interest on all other series of the June 2021 Notes is payable on June 15 and December 15 of each year, beginning on December 15, 2021. We may redeem the June 2021 Notes for cash prior to maturity. However, no make-whole premium will be paid for redemptions of the Notes Due 2023 on or after June 15, 2022, the Notes Due 2024 on or after June 14, 2023, the Notes Due 2028 on or after April 15, 2028, or the Notes Due 2031 on or after March 15, 2031. The net proceeds from the June 2021 Notes were $4.98 billion, after deducting debt discount and issuance costs. In March 2020, we issued $1.50 billion of the 2.85% Notes Due 2030, $1.00 billion of the 3.50% Notes Due 2040, $2.00 billion of the 3.50% Notes Due 2050, and $500 million of the 3.70% Notes Due 2060, or collectively, the March 2020 Notes. Interest on the March 2020 Notes is payable on April 1 and October 1 of each year. On August 16, 2021, we repaid the $1.00 billion of 2.20% Notes Due 2021. Interest on the $1.00 billion of the 3.20% Notes Due 2026, or September 2016 Notes, is payable on March 16 and September 16 of each year. The September 2016 Notes, the March 2020 Notes, and the June 2021 Notes, or collectively, the Notes, are our unsecured senior obligations. All existing and future liabilities of our subsidiaries will be effectively senior to the Notes. The carrying value of the Notes and the associated interest rates were as follows: Expected Remaining Term (years) Effective October 31, 2021 January 31, 2021 (In millions) 2.20% Notes Due 2021 — 2.38% $ — $ 1,000 0.309% Notes Due 2023 1.6 0.41% 1,250 — 0.584% Notes Due 2024 2.6 0.66% 1,250 — 3.20% Notes Due 2026 4.9 3.31% 1,000 1,000 1.55% Notes Due 2028 6.6 1.64% 1,250 — 2.85% Notes Due 2030 8.4 2.93% 1,500 1,500 2.00% Notes Due 2031 9.6 2.09% 1,250 — 3.50% Notes Due 2040 18.4 3.54% 1,000 1,000 3.50% Notes Due 2050 28.4 3.54% 2,000 2,000 3.70% Notes Due 2060 38.4 3.73% 500 500 Unamortized debt discount and issuance costs (56) (37) Net carrying amount 10,944 6,963 Less short-term portion — (999) Total long-term portion $ 10,944 $ 5,964 As of October 31, 2021, we were in compliance with the required covenants under the Notes. Commercial Paper We have a $575 million commercial paper program to support general corporate purposes. As of October 31, 2021, we had not issued any commercial paper.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Obligations Our purchase obligations primarily include our commitments to purchase components used to manufacture our products, including long-term supply agreements, certain software and technology licenses, other goods and services and long-lived assets. We recently entered into several long-term supply agreements, under which we have made advance payments and have $1.79 billion remaining unpaid. As of October 31, 2021, we had outstanding inventory purchase and long-term supply obligations totaling $6.90 billion, inclusive of the $1.79 billion, and other purchase obligations totaling $935 million. Total future unconditional purchase commitments as of October 31, 2021, are as follows: Commitments (In millions) Fiscal Year: 2022 (excluding first nine months of fiscal year 2022) $ 2,944 2023 4,637 2024 172 2025 52 2026 28 Total $ 7,833 Accrual for Product Warranty Liabilities The estimated amount of product warranty liabilities was $32 million and $22 million as of October 31, 2021 and January 31, 2021, respectively, and the activities were not significant. In connection with certain agreements that we have entered in the past, we have provided indemnities for matters such as tax, product, and employee liabilities. We have included intellectual property indemnification provisions in our technology related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability in our Condensed Consolidated Financial Statements for such indemnifications. Litigation Securities Class Action and Derivative Lawsuits The plaintiffs in the putative securities class action lawsuit, captioned 4:18-cv-07669-HSG, initially filed on December 21, 2018 in the United States District Court for the Northern District of California, and titled In Re NVIDIA Corporation Securities Litigation, filed an amended complaint on May 13, 2020. The amended complaint asserted that NVIDIA and certain NVIDIA executives violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. Plaintiffs also alleged that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. Plaintiffs sought class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses, including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On March 2, 2021, the district court granted NVIDIA’s motion to dismiss the complaint without leave to amend, entered judgment in favor of NVIDIA and closed the case. On August 11, 2021, plaintiffs filed an appeal from judgment in the United States Court of Appeals for the Ninth Circuit, case number 21-15604. The putative derivative lawsuit pending in the United States District Court for the Northern District of California, captioned 4:19-cv-00341-HSG, initially filed January 18, 2019 and titled In re NVIDIA Corporation Consolidated Derivative Litigation, remains stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. The lawsuit asserts claims for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs are seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures. The putative derivative actions initially filed September 24, 2019 and pending in the United States District Court for the District of Delaware, Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-UNA) and Nelson v. Huang, et. al. (Case No. 1:19- cv-01798- UNA), remain stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. The lawsuits assert claims for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures. Accounting for Loss Contingencies As of October 31, 2021, we have not recorded any accrual for contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while possible, are not probable. Further, except as specifically described above, any possible loss or range of loss in these matters cannot be reasonably estimated at this time. We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Oct. 31, 2021
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Capital Return Program Beginning August 2004, our Board of Directors authorized us to repurchase our stock. Through October 31, 2021, we have repurchased an aggregate of 1.04 billion shares under our share repurchase program for a total cost of $7.08 billion. All shares delivered from these repurchases have been placed into treasury stock. As of October 31, 2021, we were authorized, subject to certain specifications, to repurchase additional shares of our common stock up to $7.24 billion through December 2022. During the third quarter and first nine months of fiscal year 2022, we paid $100 million and $298 million in cash dividends to our shareholders, respectively. During the third quarter and first nine months of fiscal year 2021, we paid $99 million and $296 million in cash dividends to our shareholders, respectively.

Segment Information

Segment Information	9 Months Ended
	Oct. 31, 2021
Segment Reporting [Abstract]
Segment Information	Segment Information Our Chief Executive Officer, who is considered to be our chief operating decision maker, or CODM, reviews financial information presented on an operating segment basis for purposes of making decisions and assessing financial performance. Our two operating segments are "Graphics" and "Compute & Networking." Our operating segments are equivalent to our reportable segments. Our Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise design; GRID software for cloud-based visual and virtual computing; and automotive platforms for infotainment systems. Our Compute & Networking segment includes Data Center platforms and systems for artificial intelligence, or AI, high performance computing, or HPC, and accelerated computing; networking and interconnect solutions; automotive AI Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; cryptocurrency mining processors, or CMP; and Jetson for robotics and other embedded platforms. Operating results by segment include costs or expenses that are directly attributable to each segment, and costs or expenses that are leveraged across our unified architecture and therefore allocated between our two segments. The “All Other” category includes the expenses that our CODM does not assign to either Graphics or Compute & Networking for purposes of making operating decisions or assessing financial performance. The expenses include stock-based compensation expense, corporate infrastructure and support costs, acquisition-related costs, IP-related costs, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature. Our CODM does not review any information regarding total assets on a reportable segment basis. Depreciation and amortization expense directly attributable to each reportable segment is included in operating results for each segment. However, the CODM does not evaluate depreciation and amortization expense by operating segment and, therefore, it is not separately presented. There is no intersegment revenue. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category. Graphics Compute & Networking All Other Consolidated (In millions) Three Months Ended October 31, 2021 Revenue $ 4,092 $ 3,011 $ — $ 7,103 Operating income (loss) $ 2,160 $ 1,332 $ (821) $ 2,671 Three Months Ended October 25, 2020 Revenue $ 2,787 $ 1,939 $ — $ 4,726 Operating income (loss) $ 1,345 $ 738 $ (685) $ 1,398 Nine Months Ended October 31, 2021 Revenue $ 11,450 $ 7,821 $ — $ 19,271 Operating income (loss) $ 6,073 $ 3,227 $ (2,229) $ 7,071 Nine Months Ended October 25, 2020 Revenue $ 6,778 $ 4,894 $ — $ 11,672 Operating income (loss) $ 3,092 $ 1,880 $ (1,947) $ 3,025 Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, (In millions) Reconciling items included in "All Other" category: Stock-based compensation expense $ (559) $ (383) $ (1,453) $ (981) Acquisition-related and other costs (156) (192) (482) (669) Unallocated cost of revenue and operating expenses (106) (89) (286) (259) IP-related costs — (21) (8) (38) Total $ (821) $ (685) $ (2,229) $ (1,947) Revenue by geographic region is allocated to individual countries based on the location to which the products are initially billed even if our customers’ revenue is attributable to end customers that are located in a different location. The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, 2021 2020 2021 2020 (In millions) Revenue: Taiwan $ 2,187 $ 1,296 $ 5,932 $ 3,062 China (including Hong Kong) 2,017 1,113 5,128 2,727 Other Asia Pacific 1,067 955 3,115 2,260 United States 1,126 890 2,890 2,331 Europe 340 247 1,150 741 Other countries 366 225 1,056 551 Total revenue $ 7,103 $ 4,726 $ 19,271 $ 11,672 The following table summarizes information pertaining to our revenue by each of the specialized markets we serve: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, 2021 2020 2021 2020 (In millions) Revenue: Gaming $ 3,221 $ 2,271 $ 9,042 $ 5,264 Data Center 2,936 1,900 7,350 4,793 Professional Visualization 577 236 1,468 746 Automotive 135 125 441 391 OEM and Other 234 194 970 478 Total revenue $ 7,103 $ 4,726 $ 19,271 $ 11,672 No customer represented 10% or more of total revenue for the third quarter and first nine months of fiscal years 2022 or 2021. One customer represented 14% and 16% of our accounts receivable balance as of October 31, 2021 and January 31, 2021, respectively.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X. The January 31, 2021 consolidated balance sheet was derived from our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, as filed with the SEC, but does not include all disclosures required by U.S. GAAP. In the opinion of management, all adjustments, consisting only of normal recurring adjustments considered necessary for a fair statement of results of operations and financial position, have been included. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021. On May 21, 2021, our Board of Directors declared a four-for-one split of our common stock in the form of a stock dividend, or the Stock Split, which was conditioned upon obtaining stockholder approval to increase the number of our authorized shares of common stock from 2 billion to 4 billion. On June 3, 2021, at the 2021 Annual Meeting of Stockholders, our stockholders approved the amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock to 4 billion. As a result, each stockholder of record at the close of business on June 21, 2021 received a dividend of three additional shares of common stock for every share held on the record date, distributed after the close of trading on July 19, 2021. All share, equity award, and per share amounts and related shareholders' equity balances presented herein have been retroactively adjusted to reflect the Stock Split.
Fiscal Year	Fiscal Year We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal year 2022 is a 52-week year and fiscal year 2021 was a 53-week year. The third quarters of fiscal years 2022 and 2021 were both 13-week quarters.
Reclassifications	Reclassifications Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Principles of Consolidation	Principles of Consolidation Our condensed consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. The inputs into our judgments and estimates consider the economic implications of COVID-19. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Adoption of New and Recently Issued Accounting Pronouncement	Adoption of New and Recently Issued Accounting Pronouncement Recently Adopted Accounting Pronouncement In October 2021, the Financial Accounting Standards Board issued a new accounting standard to require that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, Revenue from Contracts with Customers . We early adopted this accounting standard in the third quarter of fiscal year 2022 and the impact was immaterial.

Business Combinations (Tables)

Business Combinations (Tables)	9 Months Ended
	Oct. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information summarizes the combined results of operations for NVIDIA and Mellanox as if the companies were combined as of the beginning of fiscal year 2020: Pro Forma Three Months Ended Nine Months Ended October 25, 2020 October 25, 2020 (In millions) Revenue $ 4,726 $ 12,101 Net income $ 1,388 $ 3,267

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2021
Leases [Abstract]
Schedule of future minimum lease payments	Future minimum lease payments under our non-cancelable operating leases as of October 31, 2021, are as follows: Operating Lease Obligations (In millions) Fiscal Year: 2022 (excluding first nine months of fiscal year 2022) $ 43 2023 169 2024 152 2025 128 2026 118 2027 and thereafter 385 Total 995 Less imputed interest 112 Present value of net future minimum lease payments 883 Less short-term operating lease liabilities 140 Long-term operating lease liabilities $ 743
Schedule of other information related to leases	Other information related to leases was as follows: Nine Months Ended October 31, 2021 October 25, 2020 (In millions) Supplemental cash flows information Operating cash flows used for operating leases $ 114 $ 103 Operating lease assets obtained in exchange for lease obligations $ 230 $ 147

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Oct. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-based compensation expense, net of amounts capitalized as inventory	Our Condensed Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, (In millions) Cost of revenue $ 44 $ 28 $ 102 $ 62 Research and development 363 232 935 594 Sales, general and administrative 152 123 416 325 Total $ 559 $ 383 $ 1,453 $ 981
Summary of equity award transactions	The following is a summary of equity award transactions under our equity incentive plans: RSUs, PSUs, and Market-based PSUs Outstanding Number of Shares Weighted Average Grant-Date Fair Value Per Share (In millions, except per share data) Balances, January 31, 2021 59 $ 66.17 Granted 17 $ 184.63 Vested restricted stock (23) $ 62.39 Canceled and forfeited (1) $ 80.50 Balances, October 31, 2021 52 $ 107.42

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Oct. 31, 2021
Earnings Per Share [Abstract]
Reconciliation of numerators and denominators of basic and diluted net income per share computations	The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, 2021 2020 2021 2020 (In millions, except per share data) Numerator: Net income $ 2,464 $ 1,336 $ 6,749 $ 2,875 Denominator: Basic weighted average shares 2,499 2,472 2,493 2,464 Dilutive impact of outstanding equity awards 39 48 39 40 Diluted weighted average shares 2,538 2,520 2,532 2,504 Net income per share: Basic (1) $ 0.99 $ 0.54 $ 2.71 $ 1.17 Diluted (2) $ 0.97 $ 0.53 $ 2.67 $ 1.15 Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive 2 — 21 32 (1) Calculated as net income divided by basic weighted average shares. (2) Calculated as net income divided by diluted weighted average shares.

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	9 Months Ended
	Oct. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	The following is a summary of cash equivalents and marketable securities as of October 31, 2021 and January 31, 2021: October 31, 2021 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 9,179 $ 2 $ (1) $ 9,180 $ 135 $ 9,045 Debt securities issued by the United States Treasury 4,887 — (2) 4,885 195 4,690 Debt securities issued by United States government agencies 2,861 — — 2,861 307 2,554 Certificates of deposit 1,512 — — 1,512 32 1,480 Money market funds 360 — — 360 360 — Foreign government bonds 241 — — 241 — 241 Total $ 19,040 $ 2 $ (3) $ 19,039 $ 1,029 $ 18,010 January 31, 2021 Amortized Unrealized Unrealized Estimated Reported as Cash Equivalents Marketable Securities (In millions) Corporate debt securities $ 4,442 $ 2 $ — $ 4,444 $ 234 $ 4,210 Debt securities issued by United States government agencies 2,975 1 — 2,976 28 2,948 Debt securities issued by the United States Treasury 2,846 — — 2,846 25 2,821 Certificates of deposit 705 — — 705 37 668 Money market funds 313 — — 313 313 — Foreign government bonds 67 — — 67 — 67 Total $ 11,348 $ 3 $ — $ 11,351 $ 637 $ 10,714
Investments Classified by Contractual Maturity Date	The amortized cost and estimated fair value of cash equivalents and marketable securities as of October 31, 2021 and January 31, 2021 are shown below by contractual maturity. October 31, 2021 January 31, 2021 Amortized Cost Estimated Fair Value Amortized Cost Estimated Fair Value (In millions) Less than one year $ 16,243 $ 16,244 $ 10,782 $ 10,783 Due in 1 - 5 years 2,797 2,795 566 568 Total $ 19,040 $ 19,039 $ 11,348 $ 11,351

Fair Value of Financial Asset_2

Fair Value of Financial Assets and Liabilities (Tables)	9 Months Ended
	Oct. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring	Fair Value at Pricing Category October 31, 2021 January 31, 2021 (In millions) Assets Cash equivalents and marketable securities: Money market funds Level 1 $ 360 $ 313 Corporate debt securities Level 2 $ 9,180 $ 4,444 Debt securities issued by the United States Treasury Level 2 $ 4,885 $ 2,846 Debt securities issued by United States government agencies Level 2 $ 2,861 $ 2,976 Certificates of deposit Level 2 $ 1,512 $ 705 Foreign government bonds Level 2 $ 241 $ 67 Other assets (Investment in non-affiliated entities): Publicly-held equity security (1) Level 1 $ 136 $ — Privately-held equity securities Level 3 $ 172 $ 144 Liabilities (2) 2.20% Notes Due 2021 Level 2 $ — $ 1,011 0.309% Notes Due 2023 Level 2 $ 1,247 $ — 0.584% Notes Due 2024 Level 2 $ 1,244 $ — 3.20% Notes Due 2026 Level 2 $ 1,086 $ 1,124 1.55% Notes Due 2028 Level 2 $ 1,233 $ — 2.85% Notes Due 2030 Level 2 $ 1,597 $ 1,654 2.00% Notes Due 2031 Level 2 $ 1,239 $ — 3.50% Notes Due 2040 Level 2 $ 1,118 $ 1,152 3.50% Notes Due 2050 Level 2 $ 2,285 $ 2,308 3.70% Notes Due 2060 Level 2 $ 594 $ 602 (1) Unrealized gains of $8 million and $126 million from an investment in a publicly-traded equity security were recorded in other income (expense), net, in the third quarter and first nine months of fiscal year 2022, respectively. (2) These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.

Amortizable Intangible Assets_2

Amortizable Intangible Assets and Goodwill (Tables)	9 Months Ended
	Oct. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortizable Intangible Assets Components	The components of our amortizable intangible assets are as follows: October 31, 2021 January 31, 2021 Gross Accumulated Net Carrying Gross Accumulated Net Carrying (In millions) Acquisition-related intangible assets (1) $ 3,396 $ (1,166) $ 2,230 $ 3,280 $ (774) $ 2,506 Patents and licensed technology 709 (485) 224 706 (475) 231 Total intangible assets $ 4,105 $ (1,651) $ 2,454 $ 3,986 $ (1,249) $ 2,737 (1) As of October 31, 2021, acquisition-related intangible assets include the fair value of a Mellanox in-process research and development project of $630 million, which has not yet commenced amortization.

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Oct. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Inventories	October 31, January 31, 2021 2021 Inventories: (In millions) Raw materials $ 755 $ 632 Work in-process 538 457 Finished goods 940 737 Total inventories $ 2,233 $ 1,826
Other Assets	October 31, January 31, 2021 2021 Other assets: (In millions) Prepaid supply agreements $ 1,606 $ — Advanced consideration for acquisition 1,357 1,357 Prepaid royalties 416 440 Investment in non-affiliated entities 308 144 Deposits 22 136 Other 52 67 Total other assets $ 3,761 $ 2,144
Accrued and Other Current Liabilities	October 31, January 31, 2021 2021 Accrued and Other Current Liabilities: (In millions) Customer program accruals $ 857 $ 630 Deferred revenue (1) 298 288 Accrued payroll and related expenses 295 297 Operating leases 140 121 Licenses and royalties 108 128 Product warranty and return provisions 45 39 Coupon interest on debt obligations 37 74 Taxes payable 36 61 Professional service fees 30 26 Other 102 61 Total accrued and other current liabilities $ 1,948 $ 1,725 (1) Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements and post-contract customer support, or PCS.
Other Long-term Liabilities	October 31, January 31, 2021 2021 Other Long-Term Liabilities: (In millions) Income tax payable (1) $ 1,051 $ 836 Deferred income tax 225 241 Deferred revenue (2) 191 163 Employee benefits 38 33 Licenses payable 21 56 Other 9 46 Total other long-term liabilities $ 1,535 $ 1,375 (1) As of October 31, 2021, income tax payable represents the long-term portion of the one-time transition tax payable of $251 million, unrecognized tax benefits of $578 million, related interest and penalties of $60 million, and other foreign long-term tax payable of $162 million. (2) Deferred revenue primarily includes deferrals related to PCS.
Movement in Deferred Revenue	The following table shows the changes in deferred revenue during the first nine months of fiscal years 2022 and 2021: October 31, October 25, 2021 2020 (In millions) Balance at beginning of period $ 451 $ 201 Deferred revenue added during the period 621 361 Addition due to business combinations — 75 Revenue recognized during the period (583) (255) Balance at end of period $ 489 $ 382

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Oct. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The table below presents the notional value of our foreign currency forward contracts outstanding as of October 31, 2021 and January 31, 2021: October 31, January 31, (In millions) Designated as cash flow hedges $ 949 $ 840 Not designated for hedge accounting $ 430 $ 441

Debt (Table)

Debt (Table)	9 Months Ended
	Oct. 31, 2021
Debt Disclosure [Abstract]
Long-term Debt	The carrying value of the Notes and the associated interest rates were as follows: Expected Remaining Term (years) Effective October 31, 2021 January 31, 2021 (In millions) 2.20% Notes Due 2021 — 2.38% $ — $ 1,000 0.309% Notes Due 2023 1.6 0.41% 1,250 — 0.584% Notes Due 2024 2.6 0.66% 1,250 — 3.20% Notes Due 2026 4.9 3.31% 1,000 1,000 1.55% Notes Due 2028 6.6 1.64% 1,250 — 2.85% Notes Due 2030 8.4 2.93% 1,500 1,500 2.00% Notes Due 2031 9.6 2.09% 1,250 — 3.50% Notes Due 2040 18.4 3.54% 1,000 1,000 3.50% Notes Due 2050 28.4 3.54% 2,000 2,000 3.70% Notes Due 2060 38.4 3.73% 500 500 Unamortized debt discount and issuance costs (56) (37) Net carrying amount 10,944 6,963 Less short-term portion — (999) Total long-term portion $ 10,944 $ 5,964

Commitment and Contingencies (T

Commitment and Contingencies (Tables)	9 Months Ended
	Oct. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Purchase Obligation, Fiscal Year Maturity	Total future unconditional purchase commitments as of October 31, 2021, are as follows: Commitments (In millions) Fiscal Year: 2022 (excluding first nine months of fiscal year 2022) $ 2,944 2023 4,637 2024 172 2025 52 2026 28 Total $ 7,833

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Oct. 31, 2021
Segment Reporting [Abstract]
Financial Information by Operating Segment	Graphics Compute & Networking All Other Consolidated (In millions) Three Months Ended October 31, 2021 Revenue $ 4,092 $ 3,011 $ — $ 7,103 Operating income (loss) $ 2,160 $ 1,332 $ (821) $ 2,671 Three Months Ended October 25, 2020 Revenue $ 2,787 $ 1,939 $ — $ 4,726 Operating income (loss) $ 1,345 $ 738 $ (685) $ 1,398 Nine Months Ended October 31, 2021 Revenue $ 11,450 $ 7,821 $ — $ 19,271 Operating income (loss) $ 6,073 $ 3,227 $ (2,229) $ 7,071 Nine Months Ended October 25, 2020 Revenue $ 6,778 $ 4,894 $ — $ 11,672 Operating income (loss) $ 3,092 $ 1,880 $ (1,947) $ 3,025
Reconciling items included in All Other category	Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, (In millions) Reconciling items included in "All Other" category: Stock-based compensation expense $ (559) $ (383) $ (1,453) $ (981) Acquisition-related and other costs (156) (192) (482) (669) Unallocated cost of revenue and operating expenses (106) (89) (286) (259) IP-related costs — (21) (8) (38) Total $ (821) $ (685) $ (2,229) $ (1,947)
Schedule of Revenue by Geographic Regions	The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, 2021 2020 2021 2020 (In millions) Revenue: Taiwan $ 2,187 $ 1,296 $ 5,932 $ 3,062 China (including Hong Kong) 2,017 1,113 5,128 2,727 Other Asia Pacific 1,067 955 3,115 2,260 United States 1,126 890 2,890 2,331 Europe 340 247 1,150 741 Other countries 366 225 1,056 551 Total revenue $ 7,103 $ 4,726 $ 19,271 $ 11,672
Schedule of Revenue by Major Markets	The following table summarizes information pertaining to our revenue by each of the specialized markets we serve: Three Months Ended Nine Months Ended October 31, October 25, October 31, October 25, 2021 2020 2021 2020 (In millions) Revenue: Gaming $ 3,221 $ 2,271 $ 9,042 $ 5,264 Data Center 2,936 1,900 7,350 4,793 Professional Visualization 577 236 1,468 746 Automotive 135 125 441 391 OEM and Other 234 194 970 478 Total revenue $ 7,103 $ 4,726 $ 19,271 $ 11,672

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details)	Jun. 21, 2021shares	Jun. 03, 2021shares	May 02, 2021shares
Accounting Policies [Abstract]
Stock split ratio		4
Authorized number of shares of common stock (in shares)		4,000,000,000	2,000,000,000
Number of additional shares issued for each currently outstanding share during stock split (in shares)	3

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) shares in Millions, $ in Millions	Sep. 13, 2020	Apr. 27, 2020	Mar. 31, 2022	Oct. 31, 2021	Oct. 25, 2020	Jan. 31, 2021
Business Acquisition [Line Items]
Advanced consideration for acquisition				$ 1,357		$ 1,357
Payments to acquire businesses, net of cash acquired				$ 203	$ 8,524
Arm Limited
Business Acquisition [Line Items]
Total cash consideration	$ 2,000
Restricted stock units issuable	1,500
Advanced consideration for acquisition	1,360
Prepaid royalties	470
Potential refund receivable	1,250
Arm Limited | Forecast
Business Acquisition [Line Items]
Merger agreement price			$ 40,000
Total cash consideration			$ 10,000
Business combination, shares issued (in shares)			177.5
Arm Limited | Maximum
Business Acquisition [Line Items]
Earnout payable	$ 5,000
Earnout shares payable (in shares)	41.3
Arm Limited | Intellectual Property License
Business Acquisition [Line Items]
Intellectual property license	$ 170
Intangible assets, useful life	20 years
Arm Limited | Prepaid Royalties
Business Acquisition [Line Items]
Intangible assets, useful life	20 years
Arm Limited | Value as of Purchase Agreement Date | Forecast
Business Acquisition [Line Items]
Business combination, shares issuable, value			$ 21,500
Arm Limited | Valuation as of November 18, 2021 | Forecast
Business Acquisition [Line Items]
Business combination, shares issuable, value			56,200
Earnout shares payable, value			$ 13,100
Mellanox Technologies, Ltd
Business Acquisition [Line Items]
Payments to acquire businesses, net of cash acquired		$ 7,130
Fair value adjustment, inventory					$ 161

Business Combination - Pro Form

Business Combination - Pro Forma Information (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 25, 2020	Oct. 25, 2020
Business Combination and Asset Acquisition [Abstract]
Revenue	$ 4,726	$ 12,101
Net income	$ 1,388	$ 3,267

Leases - Schedule of future min

Leases - Schedule of future minimum payments (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Leases [Abstract]
2022 (excluding first nine months of fiscal year 2022)	$ 43
2023	169
2024	152
2025	128
2026	118
2027 and thereafter	385
Total	995
Less imputed interest	112
Present value of net future minimum lease payments	883
Less short-term operating lease liabilities	140	$ 121
Long-term operating lease liabilities	$ 743	$ 634

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020	Jan. 31, 2021
Leases [Abstract]
Lease not yet commenced, term of contract	7 years		7 years
Operating lease, not yet commenced, amount	$ 132		$ 132
Operating lease expense	$ 44	$ 37	$ 125	$ 104
Weighted average remaining lease term - operating leases	7 years 3 months 18 days		7 years 3 months 18 days		7 years 7 months 6 days
Weighted average discount rate - operating leases	2.54%		2.54%		2.87%

Leases - Schedule of other leas

Leases - Schedule of other lease information (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020
Supplemental cash flows information
Operating cash flows used for operating leases	$ 114	$ 103
Operating lease assets obtained in exchange for lease obligations	$ 230	$ 147

Stock-Based Compensation - Allo

Stock-Based Compensation - Allocation of Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Share-based Compensation
Stock-based compensation expense	$ 559	$ 383	$ 1,453	$ 981
Cost of revenue
Share-based Compensation
Stock-based compensation expense	44	28	102	62
Research and development
Share-based Compensation
Stock-based compensation expense	363	232	935	594
Sales, general and administrative
Share-based Compensation
Stock-based compensation expense	$ 152	$ 123	$ 416	$ 325

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Equity Award Transactions (Details) - RSUs, PSUs, and Market-based PSUs shares in Millions	9 Months Ended
	Oct. 31, 2021$ / sharesshares
Number of Shares
Beginning balance (in shares) | shares	59
Granted (in shares) | shares	17
Vested restricted stock (in shares) | shares	(23)
Canceled and forfeited (in shares) | shares	(1)
Ending balance (in shares) | shares	52
Weighted Average Grant-Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 66.17
Granted (in dollars per share) | $ / shares	184.63
Vested restricted stock (in dollars per share) | $ / shares	62.39
Canceled and forfeited (in dollars per share) | $ / shares	80.50
Ending balance (in dollars per share) | $ / shares	$ 107.42

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ in Millions	9 Months Ended
	Oct. 31, 2021USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate unearned stock-based compensation expense, net of forfeitures	$ 5,160
RSUs, PSUs, and Market-based PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period	2 years 7 months 6 days
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average recognition period	1 year

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Numerator:
Net income	$ 2,464	$ 1,336	$ 6,749	$ 2,875
Denominator:
Basic weighted average shares (in shares)	2,499	2,472	2,493	2,464
Dilutive impact of outstanding equity awards (in shares)	39	48	39	40
Diluted weighted average shares (in shares)	2,538	2,520	2,532	2,504
Net income per share:
Basic (in dollars per share)	$ 0.99	$ 0.54	$ 2.71	$ 1.17
Diluted (in dollars per share)	$ 0.97	$ 0.53	$ 2.67	$ 1.15
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive (in shares)	2	0	21	32

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Oct. 31, 2021	Aug. 01, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Income Tax Contingency [Line Items]
Income tax expense	$ 174		$ 12	$ 327	$ 64
Tax expense (benefit) as percentage of income before income tax	6.60%		0.90%	4.60%	2.20%
Discrete income tax benefit, domestication		$ 252
Israel
Income Tax Contingency [Line Items]
Undistributed earnings of foreign subsidiaries	$ 1,700			$ 1,700
United Kingdom
Income Tax Contingency [Line Items]
Undistributed earnings of foreign subsidiaries	$ 231			$ 231

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Summary of Securities (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Summary of cash equivalents and marketable securities:
Amortized Cost	$ 19,040	$ 11,348
Unrealized Gain	2	3
Unrealized Loss	(3)	0
Estimated Fair Value	19,039	11,351
Reported as
Cash Equivalents	1,029	637
Marketable Securities	18,010	10,714
Corporate debt securities
Summary of cash equivalents and marketable securities:
Amortized Cost	9,179	4,442
Unrealized Gain	2	2
Unrealized Loss	(1)	0
Estimated Fair Value	9,180	4,444
Reported as
Cash Equivalents	135	234
Marketable Securities	9,045	4,210
Debt securities issued by the United States Treasury
Summary of cash equivalents and marketable securities:
Amortized Cost	4,887	2,846
Unrealized Gain	0	0
Unrealized Loss	(2)	0
Estimated Fair Value	4,885	2,846
Reported as
Cash Equivalents	195	25
Marketable Securities	4,690	2,821
Debt securities issued by United States government agencies
Summary of cash equivalents and marketable securities:
Amortized Cost	2,861	2,975
Unrealized Gain	0	1
Unrealized Loss	0	0
Estimated Fair Value	2,861	2,976
Reported as
Cash Equivalents	307	28
Marketable Securities	2,554	2,948
Certificates of deposit
Summary of cash equivalents and marketable securities:
Amortized Cost	1,512	705
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	1,512	705
Reported as
Cash Equivalents	32	37
Marketable Securities	1,480	668
Money market funds
Summary of cash equivalents and marketable securities:
Amortized Cost	360	313
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	360	313
Reported as
Cash Equivalents	360	313
Marketable Securities	0	0
Foreign government bonds
Summary of cash equivalents and marketable securities:
Amortized Cost	241	67
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	241	67
Reported as
Cash Equivalents	0	0
Marketable Securities	$ 241	$ 67

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Contractual Maturity (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Amortized Cost
Less than one year	$ 16,243	$ 10,782
Due in 1 - 5 years	2,797	566
Amortized Cost	19,040	11,348
Estimated Fair Value
Less than one year	16,244	10,783
Due in 1 - 5 years	2,795	568
Estimated Fair Value	$ 19,039	$ 11,351

Fair Value of Financial Asset_3

Fair Value of Financial Assets and Liabilities (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2021	Aug. 16, 2021	Jun. 30, 2021	Jan. 31, 2021	Mar. 31, 2020
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	$ 19,039	$ 19,039			$ 11,351
Other assets (Investment in non-affiliated entities):
Investment in non-affiliated entities	308	308			144
Liabilities
Unrealized gain recognized during the period	$ 8	$ 126
2.20% Notes Due 2021
Liabilities
Stated interest rate	2.20%	2.20%	2.20%
0.309% Notes Due 2023
Liabilities
Stated interest rate	0.309%	0.309%		0.309%
0.584% Notes Due 2024
Liabilities
Stated interest rate	0.584%	0.584%		0.584%
3.20% Notes Due 2026
Liabilities
Stated interest rate	3.20%	3.20%
1.55% Notes Due 2028
Liabilities
Stated interest rate	1.55%	1.55%		1.55%
2.85% Notes Due 2030
Liabilities
Stated interest rate	2.85%	2.85%				2.85%
2.00% Notes Due 2031
Liabilities
Stated interest rate	2.00%	2.00%		2.00%
3.50% Notes Due 2040
Liabilities
Stated interest rate	3.50%	3.50%				3.50%
3.50% Notes Due 2050
Liabilities
Stated interest rate	3.50%	3.50%				3.50%
3.70% Notes Due 2060
Liabilities
Stated interest rate	3.70%	3.70%				3.70%
Money market funds
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	$ 360	$ 360			313
Corporate debt securities
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	9,180	9,180			4,444
Debt securities issued by the United States Treasury
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	4,885	4,885			2,846
Debt securities issued by United States government agencies
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	2,861	2,861			2,976
Certificates of deposit
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	1,512	1,512			705
Foreign government bonds
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	241	241			67
Level 1
Other assets (Investment in non-affiliated entities):
Investment in non-affiliated entities	136	136			0
Level 1 | Money market funds
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	360	360			313
Level 2 | 2.20% Notes Due 2021
Liabilities
Notes	0	0			1,011
Level 2 | 0.309% Notes Due 2023
Liabilities
Notes	1,247	1,247			0
Level 2 | 0.584% Notes Due 2024
Liabilities
Notes	1,244	1,244			0
Level 2 | 3.20% Notes Due 2026
Liabilities
Notes	1,086	1,086			1,124
Level 2 | 1.55% Notes Due 2028
Liabilities
Notes	1,233	1,233			0
Level 2 | 2.85% Notes Due 2030
Liabilities
Notes	1,597	1,597			1,654
Level 2 | 2.00% Notes Due 2031
Liabilities
Notes	1,239	1,239			0
Level 2 | 3.50% Notes Due 2040
Liabilities
Notes	1,118	1,118			1,152
Level 2 | 3.50% Notes Due 2050
Liabilities
Notes	2,285	2,285			2,308
Level 2 | 3.70% Notes Due 2060
Liabilities
Notes	594	594			602
Level 2 | Corporate debt securities
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	9,180	9,180			4,444
Level 2 | Debt securities issued by the United States Treasury
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	4,885	4,885			2,846
Level 2 | Debt securities issued by United States government agencies
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	2,861	2,861			2,976
Level 2 | Certificates of deposit
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	1,512	1,512			705
Level 2 | Foreign government bonds
Cash equivalents and marketable securities:
Cash equivalents and marketable securities	241	241			67
Level 3
Other assets (Investment in non-affiliated entities):
Investment in non-affiliated entities	$ 172	$ 172			$ 144

Amortizable Intangible Assets_3

Amortizable Intangible Assets and Goodwill (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020	Jan. 31, 2021
Amortizable intangible assets components
Gross Carrying Amount	$ 4,105		$ 4,105		$ 3,986
Accumulated Amortization	(1,651)		(1,651)		(1,249)
Net Carrying Amount	2,454		2,454		2,737
Amortization expense	143	$ 174	418	$ 465
Increase in carrying amount of goodwill	109		109
Increase in carrying amount of intangible assets	119		119
Future amortization expense associated with intangible assets
Expected amortization expense, remainder of fiscal year	145		145
Expected amortization expense, year one	576		576
Expected amortization expense, year two	453		453
Expected amortization expense, year three	400		400
Expected amortization expense, year four	117		117
Expected amortization expense, year five and thereafter	133		133
Compute & Networking
Amortizable intangible assets components
Increase in carrying amount of goodwill	96		96
Graphics
Amortizable intangible assets components
Increase in carrying amount of goodwill	13		13
Acquisition-related intangible assets
Amortizable intangible assets components
Gross Carrying Amount	3,396		3,396		3,280
Accumulated Amortization	(1,166)		(1,166)		(774)
Net Carrying Amount	2,230		2,230		2,506
Patents and licensed technology
Amortizable intangible assets components
Gross Carrying Amount	709		709		706
Accumulated Amortization	(485)		(485)		(475)
Net Carrying Amount	224		224		$ 231
Mellanox Technologies, Ltd
Amortizable intangible assets components
IPR&D	$ 630		$ 630

Balance Sheet Components - Inve

Balance Sheet Components - Inventory (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Inventories:
Raw materials	$ 755	$ 632
Work in-process	538	457
Finished goods	940	737
Total inventories	$ 2,233	$ 1,826

Balance Sheet Components - Othe

Balance Sheet Components - Other Assets (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Other assets:
Prepaid supply agreements	$ 1,606	$ 0
Advanced consideration for acquisition	1,357	1,357
Prepaid royalties	416	440
Investment in non-affiliated entities	308	144
Deposits	22	136
Other	52	67
Total other assets	$ 3,761	$ 2,144

Balance Sheet Components - Accr

Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Accrued and Other Current Liabilities:
Customer program accruals	$ 857	$ 630
Deferred revenue	298	288
Accrued payroll and related expenses	295	297
Operating leases	140	121
Licenses and royalties	108	128
Product warranty and return provisions	45	39
Coupon interest on debt obligations	37	74
Taxes payable	36	61
Professional service fees	30	26
Other	102	61
Total accrued and other current liabilities	$ 1,948	$ 1,725

Balance Sheet Components - Ot_2

Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Other Long-Term Liabilities:
Income taxes payable	$ 1,051	$ 836
Deferred income tax	225	241
Deferred revenue	191	163
Employee benefits	38	33
Licenses payable	21	56
Other	9	46
Total other long-term liabilities	1,535	$ 1,375
One time transition tax payable, noncurrent	251
Unrecognized tax benefits	578
Interest and penalties related to unrecognized tax benefits	60
Foreign long-term tax payable	$ 162

Balance Sheet Components - Chan

Balance Sheet Components - Change in Deferred Revenue (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020
Change in Deferred Revenue
Balance at beginning of period	$ 451	$ 201
Deferred revenue added during the period	621	361
Addition due to business combinations	0	75
Revenue recognized during the period	(583)	(255)
Balance at end of period	$ 489	$ 382

Balance Sheet Components - Reve

Balance Sheet Components - Revenue Remaining Performance Obligation (Details) $ in Millions	Oct. 31, 2021USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revenue, remaining performance obligation	$ 620
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation (as a percent)	49.00%
Revenue, remaining performance obligation, expected timing of satisfaction	12 months

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional Values (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Designated as cash flow hedges	$ 949	$ 840
Not designated for hedge accounting	$ 430	$ 441

Derivative Financial Instrume_4

Derivative Financial Instruments - Narrative (Details)	9 Months Ended
	Oct. 31, 2021
Foreign currency forward contracts
Derivative [Line Items]
Derivative, maturity period	18 months

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)	Aug. 16, 2021	Jun. 30, 2021	Oct. 31, 2021	Oct. 25, 2020	Mar. 31, 2020
Debt Instrument [Line Items]
Issuance of debt, net of issuance costs			$ 4,977,000,000	$ 4,971,000,000
Repayments of debt			1,000,000,000	$ 0
Commercial paper outstanding			0
Commercial Paper
Debt Instrument [Line Items]
Borrowing capacity			$ 575,000,000
0.309% Notes Due 2023
Debt Instrument [Line Items]
Face amount of debt		$ 1,250,000,000
Stated interest rate		0.309%	0.309%
0.584% Notes Due 2024
Debt Instrument [Line Items]
Face amount of debt		$ 1,250,000,000
Stated interest rate		0.584%	0.584%
1.55% Notes Due 2028
Debt Instrument [Line Items]
Face amount of debt		$ 1,250,000,000
Stated interest rate		1.55%	1.55%
2.00% Notes Due 2031
Debt Instrument [Line Items]
Face amount of debt		$ 1,250,000,000
Stated interest rate		2.00%	2.00%
Notes Issued June 2021
Debt Instrument [Line Items]
Issuance of debt, net of issuance costs		$ 4,980,000,000
2.85% Notes Due 2030
Debt Instrument [Line Items]
Face amount of debt					$ 1,500,000,000
Stated interest rate			2.85%		2.85%
3.50% Notes Due 2040
Debt Instrument [Line Items]
Face amount of debt					$ 1,000,000,000
Stated interest rate			3.50%		3.50%
3.50% Notes Due 2050
Debt Instrument [Line Items]
Face amount of debt					$ 2,000,000,000
Stated interest rate			3.50%		3.50%
3.70% Notes Due 2060
Debt Instrument [Line Items]
Face amount of debt					$ 500,000,000
Stated interest rate			3.70%		3.70%
2.20% Notes Due 2021
Debt Instrument [Line Items]
Stated interest rate	2.20%		2.20%
Repayments of debt	$ 1,000,000,000
3.20% Notes Due 2026
Debt Instrument [Line Items]
Face amount of debt			$ 1,000,000,000
Stated interest rate			3.20%

Debt - Schedule of Instruments

Debt - Schedule of Instruments (Details) - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2021	Aug. 16, 2021	Jun. 30, 2021	Jan. 31, 2021	Mar. 31, 2020
Debt Instrument [Line Items]
Unamortized debt discount and issuance costs	$ (56)			$ (37)
Net carrying amount	10,944			6,963
Less short-term portion	0			(999)
Long-term debt	$ 10,944			5,964
2.20% Notes Due 2021
Debt Instrument [Line Items]
Stated interest rate	2.20%	2.20%
Effective Interest Rate	2.38%
Long-term debt, gross	$ 0			1,000
0.309% Notes Due 2023
Debt Instrument [Line Items]
Stated interest rate	0.309%		0.309%
Expected Remaining Term (years)	1 year 7 months 6 days
Effective Interest Rate	0.41%
Long-term debt, gross	$ 1,250			0
0.584% Notes Due 2024
Debt Instrument [Line Items]
Stated interest rate	0.584%		0.584%
Expected Remaining Term (years)	2 years 7 months 6 days
Effective Interest Rate	0.66%
Long-term debt, gross	$ 1,250			0
3.20% Notes Due 2026
Debt Instrument [Line Items]
Stated interest rate	3.20%
Expected Remaining Term (years)	4 years 10 months 24 days
Effective Interest Rate	3.31%
Long-term debt, gross	$ 1,000			1,000
1.55% Notes Due 2028
Debt Instrument [Line Items]
Stated interest rate	1.55%		1.55%
Expected Remaining Term (years)	6 years 7 months 6 days
Effective Interest Rate	1.64%
Long-term debt, gross	$ 1,250			0
2.85% Notes Due 2030
Debt Instrument [Line Items]
Stated interest rate	2.85%				2.85%
Expected Remaining Term (years)	8 years 4 months 24 days
Effective Interest Rate	2.93%
Long-term debt, gross	$ 1,500			1,500
2.00% Notes Due 2031
Debt Instrument [Line Items]
Stated interest rate	2.00%		2.00%
Expected Remaining Term (years)	9 years 7 months 6 days
Effective Interest Rate	2.09%
Long-term debt, gross	$ 1,250			0
3.50% Notes Due 2040
Debt Instrument [Line Items]
Stated interest rate	3.50%				3.50%
Expected Remaining Term (years)	18 years 4 months 24 days
Effective Interest Rate	3.54%
Long-term debt, gross	$ 1,000			1,000
3.50% Notes Due 2050
Debt Instrument [Line Items]
Stated interest rate	3.50%				3.50%
Expected Remaining Term (years)	28 years 4 months 24 days
Effective Interest Rate	3.54%
Long-term debt, gross	$ 2,000			2,000
3.70% Notes Due 2060
Debt Instrument [Line Items]
Stated interest rate	3.70%				3.70%
Expected Remaining Term (years)	38 years 4 months 24 days
Effective Interest Rate	3.73%
Long-term debt, gross	$ 500			$ 500

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Oct. 31, 2021	Jan. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Supply agreements	$ 1,790
Inventory purchase and long-term supply agreements	6,900
Other purchase obligations	935
Warranty accrual	$ 32	$ 22

Commitment and Contingencies -

Commitment and Contingencies - Summary of Future Commitments Due by Year (Details) $ in Millions	Oct. 31, 2021USD ($)
Fiscal Year:
2022 (excluding first nine months of fiscal year 2022)	$ 2,944
2023	4,637
2024	172
2025	52
2026	28
Total	$ 7,833

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Equity [Abstract]
Aggregated number of shares repurchased under stock repurchase program (in shares)	1,040		1,040
Aggregated cost of shares repurchased	$ 7,080		$ 7,080
Remaining authorized repurchase amount	7,240		7,240
Dividends paid	$ 100	$ 99	$ 298	$ 296

Segment Information - Summary o

Segment Information - Summary of Segments (Details) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021USD ($)	Oct. 25, 2020USD ($)	Oct. 31, 2021USD ($)segment	Oct. 25, 2020USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			2
Segment Reporting Information [Line Items]
Revenue	$ 7,103	$ 4,726	$ 19,271	$ 11,672
Operating income (loss)	2,671	1,398	7,071	3,025
Gaming
Segment Reporting Information [Line Items]
Revenue	3,221	2,271	9,042	5,264
Data Center
Segment Reporting Information [Line Items]
Revenue	2,936	1,900	7,350	4,793
Professional Visualization
Segment Reporting Information [Line Items]
Revenue	577	236	1,468	746
Automotive
Segment Reporting Information [Line Items]
Revenue	135	125	441	391
OEM and Other
Segment Reporting Information [Line Items]
Revenue	234	194	970	478
Taiwan
Segment Reporting Information [Line Items]
Revenue	2,187	1,296	5,932	3,062
China (including Hong Kong)
Segment Reporting Information [Line Items]
Revenue	2,017	1,113	5,128	2,727
Other Asia Pacific
Segment Reporting Information [Line Items]
Revenue	1,067	955	3,115	2,260
United States
Segment Reporting Information [Line Items]
Revenue	1,126	890	2,890	2,331
Europe
Segment Reporting Information [Line Items]
Revenue	340	247	1,150	741
Other countries
Segment Reporting Information [Line Items]
Revenue	366	225	1,056	551
Operating Segments | Graphics
Segment Reporting Information [Line Items]
Revenue	4,092	2,787	11,450	6,778
Operating income (loss)	2,160	1,345	6,073	3,092
Operating Segments | Compute & Networking
Segment Reporting Information [Line Items]
Revenue	3,011	1,939	7,821	4,894
Operating income (loss)	1,332	738	3,227	1,880
All Other
Segment Reporting Information [Line Items]
Revenue	0	0	0	0
Operating income (loss)	$ (821)	$ (685)	$ (2,229)	$ (1,947)

Segment Information - Reconcili

Segment Information - Reconciling Items (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2021	Oct. 25, 2020	Oct. 31, 2021	Oct. 25, 2020
Segment Reporting Information [Line Items]
Stock-based compensation expense	$ (559)	$ (383)	$ (1,453)	$ (981)
Income from operations	2,671	1,398	7,071	3,025
All Other
Segment Reporting Information [Line Items]
Stock-based compensation expense	(559)	(383)	(1,453)	(981)
Acquisition-related and other costs	(156)	(192)	(482)	(669)
Unallocated cost of revenue and operating expenses	(106)	(89)	(286)	(259)
IP-related costs	0	(21)	(8)	(38)
Income from operations	$ (821)	$ (685)	$ (2,229)	$ (1,947)

Segment Information - Concentra

Segment Information - Concentration Risk (Details)	9 Months Ended	12 Months Ended
	Oct. 31, 2021	Jan. 31, 2021
Accounts Receivable | Customer Concentration Risk | Significant Customer
Revenue, Major Customer [Line Items]
Concentration risk (as percent)	14.00%	16.00%